Bill Wexler's Dog Pound Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound

REFR 1.610

+3.6%

Dec 9 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Wexler who wrote (1738)	7/7/1999 3:54:00 PM
From: Marconi	of 10293

Hello Mr. Wexler: NVX North American Vaccine just peaked at 7-3/8 in the last hour. A story stock with less performance than Zitel. I could not get shares. It trades erratically. Negative book value. 10:1 expenses to revenues. Vaccines are a low margin business. I do not believe NVX's story of a superior vaccine, which has been their story the last decade. They received approval in the last year and sales have been marginal. Low float. Shares are usually hard to find to short. Trading volume is thin most of the time. Now that they are commercial, they should impale themselves with their performance IMHO. Best regards, m

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next